Group One Trading’s Jasper Therapeutics JSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.6K Hold
664
– – ﹤0.01% 6218
2026
Q2
$8.39K Buy
664
+634
+2,113% +$14.2K ﹤0.01% 6504
2026
Q1
$775 Buy
30
+4
+15% +$167 ﹤0.01% 7253
2025
Q4
$1.44K Sell
26
-559
-96% -$33.7K ﹤0.01% 7639
2025
Q3
$41.8K Buy
+585
New +$53.2K ﹤0.01% 6116
2025
Q1
– Sell
-17
Closed -$3.39K – 7976
2024
Q4
$10.7K Buy
+17
New +$10.6K ﹤0.01% 6069
2024
Q1
– Hold
0
– -$1 – 7493
2023
Q4
– Hold
0
– – – 7273
2023
Q3
– Sell
-28
Closed -$10.3K – 7543
2023
Q2
$11.4K Buy
+28
New +$12.5K ﹤0.01% 6328
2023
Q1
– Sell
-1
Closed -$555 – 7566
2022
Q4
$143 Hold
1
– – ﹤0.01% 7055
2022
Q3
$0 Hold
1
– – ﹤0.01% 7866
2022
Q2
$1K Buy
+1
New +$854 ﹤0.01% 7559

Other funds holding JSPR

Group One Trading's JSPR Position: Q3 2026 in Review

Group One Trading held its Jasper Therapeutics (JSPR) position steady in Q3 2026 at 664 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6218.

Group One Trading first reported a position in JSPR in Q2 2022 and has held it in 10 quarters since. The position peaked at $41.8K in Q3 2025. 50 funds tracked by Wall St. Rank hold JSPR as of Q3 2026.

  • Group One Trading held 664 shares of Jasper Therapeutics worth $11.6K as of Q3 2026.
  • Group One Trading left its Jasper Therapeutics share count unchanged in Q3 2026.
  • Jasper Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #6218 holding.
  • Group One Trading first reported a position in Jasper Therapeutics in Q2 2022 and has held it in 10 quarters since.
  • Group One Trading's Jasper Therapeutics position peaked at $41.8K in Q3 2025.
  • 50 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.